IE46995B1 - Mercaptoacylamidobenzoyl glycine - Google Patents

Mercaptoacylamidobenzoyl glycine

Info

Publication number
IE46995B1
IE46995B1 IE1194/78A IE119478A IE46995B1 IE 46995 B1 IE46995 B1 IE 46995B1 IE 1194/78 A IE1194/78 A IE 1194/78A IE 119478 A IE119478 A IE 119478A IE 46995 B1 IE46995 B1 IE 46995B1
Authority
IE
Ireland
Prior art keywords
mercapto
salt
acetylamino
compound
glycine
Prior art date
Application number
IE1194/78A
Other languages
English (en)
Other versions
IE781194L (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE781194L publication Critical patent/IE781194L/xx
Publication of IE46995B1 publication Critical patent/IE46995B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE1194/78A 1977-06-15 1978-06-14 Mercaptoacylamidobenzoyl glycine IE46995B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/806,877 US4093739A (en) 1977-06-15 1977-06-15 Mercaptoacylamidobenzoyl glycine and mucolytic process

Publications (2)

Publication Number Publication Date
IE781194L IE781194L (en) 1978-12-15
IE46995B1 true IE46995B1 (en) 1983-11-30

Family

ID=25195031

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1194/78A IE46995B1 (en) 1977-06-15 1978-06-14 Mercaptoacylamidobenzoyl glycine

Country Status (21)

Country Link
US (2) US4093739A (member.php)
JP (1) JPS545933A (member.php)
AU (1) AU520094B2 (member.php)
BE (1) BE868114A (member.php)
CA (1) CA1132607A (member.php)
CH (1) CH635067A5 (member.php)
DE (1) DE2825931C2 (member.php)
DK (1) DK268478A (member.php)
ES (1) ES470825A1 (member.php)
FI (1) FI71307C (member.php)
FR (1) FR2394526A1 (member.php)
GB (1) GB2001958B (member.php)
GR (1) GR73530B (member.php)
IE (1) IE46995B1 (member.php)
IT (1) IT1107483B (member.php)
LU (1) LU79805A1 (member.php)
NL (1) NL7806360A (member.php)
PH (1) PH13512A (member.php)
SE (1) SE441526B (member.php)
YU (1) YU40195B (member.php)
ZA (1) ZA783443B (member.php)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
US5432186A (en) * 1993-11-16 1995-07-11 Ciba-Geigy Corporation Cyclic amino acid derivatives
EP0655461B1 (en) * 1993-11-16 2000-06-07 Novartis AG Cyclic amino acid derivatives having ACE and NEP inhibiting activity
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
JP3261969B2 (ja) * 1996-02-29 2002-03-04 豊田合成株式会社 ホースとその製造方法
US6294695B1 (en) 1998-03-26 2001-09-25 Mount Sinai School Of Medicine Of The City University Of New York Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
JP2003106051A (ja) * 2001-09-28 2003-04-09 Tostem Corp サッシ
US6797319B2 (en) * 2002-05-31 2004-09-28 Kimberly-Clark Worldwide, Inc. Application of foam to tissue products using a liquid permeable partition
WO2019051182A1 (en) 2017-09-07 2019-03-14 The Children's Hospital Of Philadelphia COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYSTATIN C-HISTORY AMYLOID ANGIOPATHY (HCCAA) AND OTHER NEURODEGENERATIVE DISORDERS ASSOCIATED WITH ABERRANT AMYLOID DEPOTS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520293A (en) * 1947-01-30 1950-08-29 Endo Products Inc Mercaptoacetanilide derivatives
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
US3663690A (en) * 1969-08-12 1972-05-16 Hoechst Co American Mucolytic composition and method of treatment of broncho-pulmonary disorders therewith
BE789811A (fr) * 1971-10-07 1973-04-06 Bristol Myers Co 1,4-bis-acylpiperazines
BE789838A (fr) * 1971-10-13 1973-02-01 Cerm Cent Europ Rech Mauvernay Nouveaux derives de la cysteine et leur application en therapeutique
FR2187327B1 (member.php) * 1972-06-15 1975-06-20 Rech Pharm Scientifiques
US3971828A (en) * 1972-10-03 1976-07-27 Santen Pharmaceutical Co. Ltd. N-(mercaptoacyl)aminoacids
US3857951A (en) * 1973-09-14 1974-12-31 Cassenne Lab Sa Use of 2-mercaptopropionylglycine and its alkali metal salts in treating respiratory diseases
US4005222A (en) * 1975-05-21 1977-01-25 Mead Johnson & Company Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process

Also Published As

Publication number Publication date
JPS6225657B2 (member.php) 1987-06-04
FR2394526B1 (member.php) 1980-07-04
US4093739A (en) 1978-06-06
DK268478A (da) 1978-12-16
AU520094B2 (en) 1982-01-14
NL7806360A (nl) 1978-12-19
CA1132607A (en) 1982-09-28
CH635067A5 (de) 1983-03-15
SE441526B (sv) 1985-10-14
FI71307C (fi) 1986-12-19
ZA783443B (en) 1979-06-27
BE868114A (fr) 1978-12-14
DE2825931C2 (de) 1987-01-29
LU79805A1 (fr) 1979-02-02
AU3711278A (en) 1979-12-20
GR73530B (member.php) 1984-03-12
GB2001958A (en) 1979-02-14
IT7849864A0 (it) 1978-06-14
GB2001958B (en) 1982-02-03
US4132803A (en) 1979-01-02
SE7806880L (sv) 1978-12-16
JPS545933A (en) 1979-01-17
YU137578A (en) 1983-01-21
IE781194L (en) 1978-12-15
YU40195B (en) 1985-08-31
FR2394526A1 (fr) 1979-01-12
FI781866A7 (fi) 1978-12-16
ES470825A1 (es) 1979-10-01
IT1107483B (it) 1985-11-25
FI71307B (fi) 1986-09-09
DE2825931A1 (de) 1979-01-04
PH13512A (en) 1980-06-03

Similar Documents

Publication Publication Date Title
US4005222A (en) Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process
AU657827B2 (en) Organic salts of N, N'-diacetyl cystine
IE46995B1 (en) Mercaptoacylamidobenzoyl glycine
EP2742048B1 (en) Inhibiting transient receptor potential ion channel trpa1
US8765153B2 (en) Levalbuterol salt
WO2020093097A1 (en) Compounds and compositions for the treatment of respiratory diseases
US3839584A (en) Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
JPS58131959A (ja) 新規アミノ酸誘導体の製法
US4132802A (en) Benzoic acid derivative and benzenesulfonic acid mucolytic process
US3898338A (en) 1,4-Bis-acylpiperazine mucolytic process
US3809697A (en) 1,4-bis-acylpiperazines
NZ209330A (en) Oxybenzene derivatives and pharmaceutical compositions
CA2098298A1 (en) Aerosol formulations
US4178301A (en) Benzoic acid derivatives
CA1119610A (en) L-cysteine derivatives and medicaments containing them
EP0037187B1 (en) Salts and aqueous solutions of 6-methylamino-4-oxo-10-propyl-4h-pyrano(3,2-g)-quinoline-2,8-di-carboxylic acid and pharmaceutical compositions containing such salts and solutions
IE61181B1 (en) New derivatives of cysteine
EP0906275B1 (en) New forms of organic salts of n'n-diacetylcystine
ME00246B (me) Formulacije hfa-suspenzija koje sadrže anhidrat
KR860001311B1 (ko) 2-테노일메르캅토프로피온일글리신과 치환 히드록시벤젠류와의 에스테르 제조방법
DE69616335T2 (de) Ein triazolylmethyl-indol-ethylamin-bisulfat-salz
IE45519B1 (en) Sulfur-containing n-(o-aminobenzyl)-amino acids and esters